We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for British citizens moving to or living in Madagascar, including guidance on residency, healthcare, education and more.
Across the Sahel sub-region, most childhood malaria mortality and morbidity occurs during the short rainy season
Product Safety Report for Makari De Suisse - Active Intense Tone Boosting Gel presenting a serious chemical risk.
Product Safety Report for Makari De Suisse Multi-Action Extreme Glow Revitalizing Face Serum presenting a serious chemical risk.
Product Safety Report for Makari De Suisse Intense Extreme Rejuvenating Face Serum presenting a serious chemical risk.
Examines the effects of treating people with artemether injected intramuscularly compared to treatment with other antimalarial drugs
To compare artesunate with quinine for treating severe malaria.
Researchers conducted a review of the effects of pre-referral rectal artesunate for people with suspected severe malaria
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).